122 related articles for article (PubMed ID: 29927416)
1. [Scales and tests in the rehabilitation and treatment of patients with spasticity of the lower limbs].
Kovalenko AP; Kamaeva OV; Misikov VK; Poleshchuk YR; Koshkarev MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):120-128. PubMed ID: 29927416
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin in treatment of lower limb spasticity in patients with brain damage].
Kovalenko AP; Misikov VK
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):28-34. PubMed ID: 30335069
[TBL] [Abstract][Full Text] [Related]
3. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
Nott MT; Barden HL; Baguley IJ
J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
6. [Scales and tests in the rehabilitation and treatment of patients with spasticity of the upper limbs].
Kovalenko AP; Kamaeva OV; Poleshchuk YR; Kovlen DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):107-114. PubMed ID: 32490627
[TBL] [Abstract][Full Text] [Related]
7. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
9. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
Demetrios M; Brand C; Louie J; Khan F
J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
[TBL] [Abstract][Full Text] [Related]
10. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
[TBL] [Abstract][Full Text] [Related]
11. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
[TBL] [Abstract][Full Text] [Related]
12. Management of upper and lower limb spasticity in neuro-rehabilitation.
Hesse S; Werner C; Bardeleben A; Brandl-Hesse B
Acta Neurochir Suppl; 2002; 79():117-22. PubMed ID: 11974976
[TBL] [Abstract][Full Text] [Related]
13. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
[TBL] [Abstract][Full Text] [Related]
14. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
[TBL] [Abstract][Full Text] [Related]
15. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
16. Measuring spasticity and fine motor control (pinch) change in the hand after botulinum toxin-A injection using dynamic computerized hand dynamometry.
Barden HL; Baguley IJ; Nott MT; Chapparo C
Arch Phys Med Rehabil; 2014 Dec; 95(12):2402-9. PubMed ID: 24909588
[TBL] [Abstract][Full Text] [Related]
17. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
Pennati GV; Da Re C; Messineo I; Bonaiuti D
Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
Sheean G
Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
20. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
